Retirement Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$41K Hold
500
0.01% 259
2023
Q4
$9.3K Buy
+500
New +$6.54K ﹤0.01% 460
2023
Q3
Sell
-2,100
Closed -$34K 831
2023
Q2
$34K Buy
2,100
+900
+75% +$18.9K 0.01% 246
2023
Q1
$20K Hold
1,200
0.01% 305
2022
Q4
$11K Buy
+1,200
New +$5.36K 0.01% 348
2020
Q4
Sell
-2,000
Closed -$12K 740
2020
Q3
$12K Hold
2,000
0.01% 398
2020
Q2
$14K Buy
+2,000
New +$13.3K 0.01% 356
2019
Q4
$18K Buy
+2,200
New +$16K 0.01% 338

Other funds holding VKTX

Retirement Group's VKTX Position: Q1 2024 in Review

Retirement Group held its Viking Therapeutics (VKTX) position steady in Q1 2024 at 500 shares worth $41K. The position accounts for 0.01% of the portfolio, ranked #259.

Retirement Group first reported a position in VKTX in Q4 2019 and has held it in 8 quarters since. 375 funds tracked by Wall St. Rank hold VKTX as of Q1 2024.

  • Retirement Group held 500 shares of Viking Therapeutics worth $41K as of Q1 2024.
  • Retirement Group left its Viking Therapeutics share count unchanged in Q1 2024.
  • Viking Therapeutics made up 0.01% of Retirement Group's portfolio in Q1 2024, its #259 holding.
  • Retirement Group first reported a position in Viking Therapeutics in Q4 2019 and has held it in 8 quarters since.
  • 375 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.